The re-emergence of COVID-19 in China is a big threat for the world: Associated risk factors and preventive measures

Barai, Sampa; Kadir, Mohammad Fahim; Shahriar, Mohammad; Islam, Md. Rabiul

doi:10.1097/ms9.0000000000000219

Cited by 6 publications

(8 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[80][81][82][83][84][85][86] Countries across the world need to accelerate their vaccination campaign at least 20 times to reach 70% global coverage. [87][88][89][90]…”

Section: Discussionmentioning

confidence: 99%

Comparative Performance Evaluation of Personal Protective Measures and Antiviral Agents Against SARS-CoV-2 Variants: A Narrative Review

Haque

Tanbir

Ahamed

et al. 2023

Clin Med�Insights�Pathol

Self Cite

View full text Add to dashboard Cite

Scientists identified SARS-CoV-2 in December 2019 in Wuhan city of China. Soon after its identification, Covid-19 spreads almost everywhere. The World Health Organization (WHO) declared the Covid-19 outbreak as a pandemic on March 11, 2020. Countries are facing multiple waves due to the different variants of the coronavirus. Personal preventive measures, vaccines, and antiviral drugs are the approaches to control Covid-19. However, these approaches are being implemented in different countries at different levels because of the availability of personal protective measures and antiviral agents. The objective of this study was to evaluate the effectiveness of practicing measures to fight the Covid-19 pandemic. Here we searched relevant literature from PubMed and Scopus using the keywords such as personal protective measures, antiviral agents, and vaccine effectiveness. According to the present findings, protective measures were found comparatively less effective. Nevertheless, these measures can be used to limit the spreading of Covid-19. Antiviral agents can reduce the hospitalization rate and are more effective than personal protective measures. The most effective strategy against Covid-19 is early vaccination or multiple vaccination dose. The respective authorities should ensure equal distribution of vaccines, free availability of antiviral drugs, and personal protective measure in poor and developing countries. We recommend more studies to describe the effectiveness of practicing preventive measures and antiviral agents against recent variants of the coronavirus.

show abstract

“…[80][81][82][83][84][85][86] Countries across the world need to accelerate their vaccination campaign at least 20 times to reach 70% global coverage. [87][88][89][90]…”

Section: Discussionmentioning

confidence: 99%

Comparative Performance Evaluation of Personal Protective Measures and Antiviral Agents Against SARS-CoV-2 Variants: A Narrative Review

Haque

Tanbir

Ahamed

et al. 2023

Clin Med�Insights�Pathol

Self Cite

View full text Add to dashboard Cite

show abstract

“…[18][19][20] This mutation may increase the power of the Marburg virus in terms of virulence, transmissibility, mortality, and morbidity rate. [21][22][23][24][25] Therefore, it can become a potential threat to COVID-19 has already impacted the mental health of people of all classes. [27][28][29][30] Therefore, the recent MVD outbreaks will have…”

Section: Mvd An Emerging Public Health Threatmentioning

confidence: 99%

“…Being an RNA virus, the Marburg virus is also prone to mutation like COVID‐19 18–20 . This mutation may increase the power of the Marburg virus in terms of virulence, transmissibility, mortality, and morbidity rate 21–25 . Therefore, it can become a potential threat to public health worldwide.…”

Section: Mvd An Emerging Public Health Threatmentioning

confidence: 99%

The recent outbreaks of Marburg virus disease in African countries are indicating potential threat to the global public health: Future prediction from historical data

Idbaïh

Salsabil

Hossain

et al. 2023

Health Science Reports

Self Cite

View full text Add to dashboard Cite

Marburg virus disease (MVD) caused by the Marburg virus has a high mortality rate. Rousettus aegyptiacus fruit bats act as the natural reservoir host of the virus. But it can also potentially be transmitted from person to person through direct contact with body secretions. The recent outbreaks have already killed seven people out of nine confirmed cases in Equatorial Guinea and five patients out of eight confirmed cases in Tanzania. In the recent past, Ghana reported three MVD cases and two associated deaths in 2022. Specific treatments or vaccines are unavailable for MVD, and supportive care is the primary treatment option. The history of MVD outbreaks and the current scenario show its potential to become an emerging threat to global public health. The recent outbreaks in Tanzania and Equatorial Guinea have already caused a high fatality rate. The absence of effective treatment and vaccines raises concerns about the potential to cause widespread harm. Besides, its capacity for human‐to‐human transmission and potential to cross the country's border could result in a multicountry outbreak. Therefore, we recommend intensive surveillance of MVD, preventative measures, and early detection to limit the spread of the disease and prevent another pandemic.

show abstract

“…With physical distancing measures in place to limit the spread of the virus, telehealth services have enabled patients to consult with healthcare providers. 25,26 It has also been used for COVID-19 screening, enabling healthcare professionals to assess patients for COVID-19 symptoms and provide guidance on the next steps. Again, healthcare facilities have implemented several measures to control COVID-19.…”

Section: The Global Preparedness Against Covid-19mentioning

confidence: 99%

The WHO has declared the end of pandemic phase of COVID‐19: Way to come back in the normal life

Sarker,

Roknuzzaman,

Nazmunnahar

et al. 2023

Health Science Reports

Self Cite

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID‐19) pandemic has resulted in significant global mortality and morbidity affecting millions of lives. As healthcare authorities worldwide are still paying substantial attention to COVID‐19, other diseases continue to cause more deaths than COVID‐19. The decreasing number of COVID‐19 cases and deaths indicates that the pandemic is close to the end. For effective pandemic management, healthcare facilities worldwide have established COVID‐19 units and testing facilities, instituting infection prevention and control measures, and employing telehealth services. Healthcare professionals have identified some promising treatments for COVID‐19; also, mass vaccinations have improved patient outcomes. Instead of COVID‐19 as a pandemic, it is time to pay more attention to other diseases to lessen their impact on public health. Therefore, the World Health Organization (WHO) has declared the end of the pandemic phase of COVID‐19 considering the current COVID‐19 situation and our preparedness, past pandemic experience, and long pandemic impact on social and economic life on May 5, 2023. In this article, we briefly discussed the present challenges due to COVID‐19, necessary precautions, and future directions to return to life as before COVID‐19.

show abstract

The re-emergence of COVID-19 in China is a big threat for the world: Associated risk factors and preventive measures

Cited by 6 publications

References 12 publications

Comparative Performance Evaluation of Personal Protective Measures and Antiviral Agents Against SARS-CoV-2 Variants: A Narrative Review

Comparative Performance Evaluation of Personal Protective Measures and Antiviral Agents Against SARS-CoV-2 Variants: A Narrative Review

The recent outbreaks of Marburg virus disease in African countries are indicating potential threat to the global public health: Future prediction from historical data

The WHO has declared the end of pandemic phase of COVID‐19: Way to come back in the normal life

Contact Info

Product

Resources

About